Research Article
Pharmacological Mechanisms of Tinglizi against Chronic Heart Failure Determined by Network Pharmacology and Molecular Docking
Table 1
Effective components of Tinglizi
| Mol ID | Molecule name | OB (%) | DL |
| MOL002211 | 11,14-Eicosadienoic acid | 39.99 | 0.2 | MOL000296 | Hederagenin | 36.91 | 0.75 | MOL000354 | Isorhamnetin | 49.6 | 0.31 | MOL000358 | β-Sitosterol | 36.91 | 0.75 | MOL003905 | K-STROPHANTHOSIDE | 70.65 | 0.22 | MOL003906 | K-STROPHANTHOSIDE_qt | 30.8 | 0.78 | MOL003907 | Erysimoside | 65.45 | 0.23 | MOL003908 | Cynotoxin | 99.94 | 0.78 | MOL003909 | Evobioside | 44.25 | 0.24 | MOL003927 | Dihomolinolenic acid | 44.11 | 0.2 | MOL000422 | Kaempferol | 41.88 | 0.24 | MOL000098 | Quercetin | 46.43 | 0.28 |
|
|